ImaginAb founder Dr Anna Wu will be presenting at EANM this week. The European congress which attracted almost 7000 attendees in 2019, will be virtual this year.
Dr Wu will present at Joint Symposium 12 in the on-demand pool on Wednesday October 20th at 09:00 CET on the subject “Molecular Imaging of the Immune System” Dr Wu will be describing approaches for PET imaging of immune cells, including Phase I and Phase II results using Zr-89-crefmirlimab for detection of CD8 T cells in patients.
Our CD8 technology will be presented in the Cutting Edge Science Track - TROP Session: Imaging of Non-Standard Radionuclides presentation, “USE of 89Zr-Crefmirlimab (CD8) PET for Directing Solid Tumor Biopsy” by David Hays MD, Edgar St. Amour MD, Carla Randall MHSA,CCRP, Ian Wilson PhD, William Le MS, and Ron Korn, MD, PhD
